Literature DB >> 26115616

Management of late extraneural recurrence of medulloblastoma without high-dose chemotherapy.

Richard E Phillips1, Kevin J Curran2, Yasmin Khakoo2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26115616      PMCID： PMC4981478          DOI： 10.1007/s11060-015-1850-x

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  4 in total

1.  Unusual case of recurrent extraneural metastatic medulloblastoma in a young adult: durable complete remission with Ewing sarcoma chemotherapy regimen and consolidation with autologous bone marrow transplantation and local radiation.

Authors:  Jincy Clement; John Varlotto; Witold Rybka; Elizabeth Frauenhoffer; Joseph J Drabick
Journal:  J Clin Oncol       Date:  2013-05-28       Impact factor: 44.544

2.  High dose chemotherapy with autologous stem cell rescue in adults with malignant primary brain tumors.

Authors:  L E Abrey; M K Rosenblum; E Papadopoulos; B H Childs; J L Finlay
Journal:  J Neurooncol       Date:  1999-09       Impact factor: 4.130

3.  High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group.

Authors:  I J Dunkel; J M Boyett; A Yates; M Rosenblum; J H Garvin; B C Bostrom; S Goldman; L S Sender; S L Gardner; H Li; J C Allen; J L Finlay
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

4.  Treatment of extraneural metastatic medulloblastoma with a combination of cyclophosphamide, adriamycin, and vincristine.

Authors:  M C Chamberlain; P Silver; M S Edwards; V A Levin
Journal:  Neurosurgery       Date:  1988-10       Impact factor: 4.654
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.